France Antiviral Drugs Market to 2032
Overview
The France Antiviral Drugs Market is expected to reach a 4.10 USD Billion by 2032 and is projected to grow at a CAGR of 8.39% from 2025 to 2032.
Revenue, 2024 (USD Billion)
2.60
Forecast, 2032 (USD Billion)
4.10
CAGR, 2024 - 2032
8.39%
Report Coverage
France
France Antiviral Drugs Market 2018-2032 USD Billion
France Antiviral Drugs Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 2.60 USD Billion
- Projected Market Size (2032): 4.10 USD Billion
- CAGR (2025-2032): 8.39%
Key Findings of France Antiviral Drugs Market
- The France Antiviral Drugs Market was valued at 2.60 USD Billion in 2024.
- The France Antiviral Drugs Market is likely to grow at a CAGR of 8.39% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Topical in Products Segment accounted for the largest share of the market with a revenue of 2.60 USD Billion
- The fastest growing segment Influenza in Indication Segment grew Fastest with a CAGR of 11.12% during the forecast period from 2024 to 2032.
France Antiviral Drugs Market Scope
France Antiviral Drugs Market Segmentation & Scope
Indication
- Others
- Coronavirus Infection
- Respiratory Syncytial Virus
- Hepatitis B Virus
- Varicella-Zoster Virus (VZV)
- Human Cytomegalovirus (HCMV)
- Herpes Simplex Virus
- Hepatitis C Virus
- Human Immunodeficiency Virus (HIV)
- Influenza
Products
- Parenteral
- Oral
- Topical
Drug
- Branded
- Generic
End User
- Others
- Home Healthcare
- Clinics
- Ambultatory Centres
- Speciality Centers
- Hospitals
Patient
- Adult
- Child
- Geriatric
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
France Antiviral Drugs Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 2.60 USD Billion |
| Market Value in 2032 | 4.10 USD Billion |
| CAGR (2025-2032) | 8.39% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Indication,Products,Drug,End User,Patient,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): France, leading in terms of revenue 2.60 USD Billion in 2024
- Key Country: France, leading in terms of revenue with value of 2,600.52 USD Million in 2024.
Segments and Scope
-
France Antiviral Drugs Market to 2032, By Indication
- Influenza is the largest segment in France Antiviral Drugs Market to 2032 with a revenue of 835.12 USD Billion in the year 2024.
- Influenza is the Fastest growing segment in France Antiviral Drugs Market to 2032 with a Growth rate of 11.12 % in forecast period 2025-2032.
-
France Antiviral Drugs Market to 2032, By Products
- Topical is the largest segment in France Antiviral Drugs Market to 2032 with a revenue of 2.60 USD Billion in the year 2024.
- Oral is the Fastest growing segment in France Antiviral Drugs Market to 2032 with a Growth rate of 8.39 % in forecast period 2025-2032.
-
France Antiviral Drugs Market to 2032, By Drug
- Generic is the largest segment in France Antiviral Drugs Market to 2032 with a revenue of 1.67 USD Billion in the year 2024.
- Generic is the Fastest growing segment in France Antiviral Drugs Market to 2032 with a Growth rate of 8.77 % in forecast period 2025-2032.
-
France Antiviral Drugs Market to 2032, By End User
- Hospitals is the largest segment in France Antiviral Drugs Market to 2032 with a revenue of 1.31 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in France Antiviral Drugs Market to 2032 with a Growth rate of 9.91 % in forecast period 2025-2032.
-
France Antiviral Drugs Market to 2032, By Patient
- Adult is the largest segment in France Antiviral Drugs Market to 2032 with a revenue of 1.23 USD Billion in the year 2024.
- Adult is the Fastest growing segment in France Antiviral Drugs Market to 2032 with a Growth rate of 9.93 % in forecast period 2025-2032.
-
France Antiviral Drugs Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in France Antiviral Drugs Market to 2032 with a revenue of 1.36 USD Billion in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in France Antiviral Drugs Market to 2032 with a Growth rate of 9.67 % in forecast period 2025-2032.
France Antiviral Drugs Market Company Share Analysis
| Company Name |
|
||
| Teva Pharmaceutical Industries Ltd. | |||
| Pfizer Inc. | |||
| Gilead Sciences, Inc. | |||
| GSK plc. | |||
| F. Hoffmann-La Roche Ltd. | |||
France Antiviral Drugs Market Geographical Sales Distribution, 2018-2032 USD Billion
France Antiviral Drugs Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The France Antiviral Drugs Market is segmented based on Segmentation Indication,Products,Drug,End User,Patient,Distribution Channel.
France Antiviral Drugs Market was valued at USD 2.60(Revenue in USD Billion) in 2021.
France Antiviral Drugs Market is projected to grow at a CAGR of 8.39% during the forecast period of 2024 to 2032.
The Topical segment is expected to dominate the France Antiviral Drugs Market, holding a largest market share of 2.60 USD Billion in 2024
France Antiviral Drugs Market Scope
France Antiviral Drugs Market Segmentation & Scope
Indication
- Others
- Coronavirus Infection
- Respiratory Syncytial Virus
- Hepatitis B Virus
- Varicella-Zoster Virus (VZV)
- Human Cytomegalovirus (HCMV)
- Herpes Simplex Virus
- Hepatitis C Virus
- Human Immunodeficiency Virus (HIV)
- Influenza
Products
- Parenteral
- Oral
- Topical
Drug
- Branded
- Generic
End User
- Others
- Home Healthcare
- Clinics
- Ambultatory Centres
- Speciality Centers
- Hospitals
Patient
- Adult
- Child
- Geriatric
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Frequently Asked Questions
The France Antiviral Drugs Market is segmented based on Segmentation Indication,Products,Drug,End User,Patient,Distribution Channel.
France Antiviral Drugs Market was valued at USD 2.60(Revenue in USD Billion) in 2021.
France Antiviral Drugs Market is projected to grow at a CAGR of 8.39% during the forecast period of 2024 to 2032.
The estimated market value of the France Antiviral Drugs Market for final year is USD 4.10 (USD Billion).
France Antiviral Drugs Market Company Profiling
Frequently Asked Questions
The France Antiviral Drugs Market is segmented based on Segmentation Indication,Products,Drug,End User,Patient,Distribution Channel.
France Antiviral Drugs Market was valued at USD 2.60(Revenue in USD Billion) in 2021.
France Antiviral Drugs Market is projected to grow at a CAGR of 8.39% during the forecast period of 2024 to 2032.
The estimated market value of the France Antiviral Drugs Market for final year is USD 4.10 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.